P25023 Pneumo Vax Pre-Assessment – Medical Learning Institute Inc

Pneumo Vax Pre-Assessment

Name

First

Last

Email

NPI Number

Conference Location

If other (please specify):

What is your primary specialty?

Family medicine
Internal medicine
Other

1. Which combination best represents the most common clinical manifestations of pneumococcal disease?

a. Pneumonia, otitis media, cellulitis
b. Pneumonia, sinusitis, urinary tract infection
c. Pneumonia, conjunctivitis, endocarditis
d. Pneumonia, bacteremia, meningitis

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

2. What are the current recommendations regarding age-based eligibility for pneumococcal vaccination?

a. All adults should receive pneumococcal vaccination at age 50
b. Only adults over 65 are recommended to receive pneumococcal vaccines
c. Adults aged 50 to 64 are now eligible only if they have chronic lung disease
d. Only immunocompromised adults should receive pneumococcal vaccination at age 50

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

3. A 68-year-old male received PPSV23 at age 65. He has no history of PCV13, PCV20, or PCV21. What is the next step for vaccination for this patient?

a. No further vaccination is needed
b. Give PCV13 now, followed by PPSV23 in 1 year
c. Give PCV20 or PCV21 now
d. Wait until age 70 to reassess pneumococcal vaccination

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

4. A 45-year-old female with lupus on immunosuppressive therapy has never received a pneumococcal vaccine. What is the next step for vaccination for this patient?

a. PCV15
b. PCV20 or PCV21
c. PPSV23
d. Do not vaccinate given she is immunocompromised

appropriate you to

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

5. A 72-year-old man received PCV15 today. Would it have been appropriate to give PCV20 or PCV21 instead of PCV15 in this patient?

a. No, PCV20 or PCV21 are not recommended in patients ≥ 65
b. Yes, PCV20 or PCV21 can be used alone in adults ≥ 65
c. Only if the patient previously received PCV13
d. Only if PPSV23 was already given

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

6. Which strategy should your care team use to support increased pneumococcal vaccine uptake in eligible adults?

a. Initiate vaccine discussions using clinical data
b. Use the CASE approach selectively for hesitant patients
c. Use motivational interviewing during routine encounters
d. Centralize vaccine discussions to annual wellness visits

Please select the extent to which you feel confident in your answer:

Completely confident	Fairly confident	Somewhat confident	Slightly confident	Not confident
Completely confidentItem #1 Completely confident	Fairly confidentItem #1 Fairly confident	Somewhat confidentItem #1 Somewhat confident	Slightly confidentItem #1 Slightly confident	Not confidentItem #1 Not confident

7. How confident are you in your ability to evaluate eligible adults for pneumococcal disease risk and provide available vaccination(s) after having a clear conversation with the patient?